Insmed (INSM) Cash & Current Investments (2010 - 2026)

Insmed's Cash & Current Investments history runs 17 years deep, the most recent figure standing at $1.2 billion for Q1 2026.

• On a quarterly basis, Cash & Current Investments rose 2.01% year-over-year to $1.2 billion in Q1 2026; TTM through Mar 2026 was $1.2 billion, a 2.01% increase from a year earlier, with the FY2025 full-year figure at $1.4 billion, changed 0.26% from the prior year.
• Cash & Current Investments slipped to $1.2 billion in Q1 2026 per INSM's latest filing, from $1.4 billion in the prior quarter.
• Across five years, Cash & Current Investments topped out at $1.9 billion in Q2 2025 and bottomed at $513.3 million in Q3 2022.
• The 5-year median for Cash & Current Investments is $1.1 billion (2022), against an average of $1.1 billion.
• Across the five-year window, Cash & Current Investments sank 40.35% in 2024 and soared 101.34% in 2025, its largest moves.
• Year by year, Cash & Current Investments stood at $1.1 billion in 2022, then sank by 32.03% to $780.4 million in 2023, then surged by 83.72% to $1.4 billion in 2024, then decreased by 0.26% to $1.4 billion in 2025, then fell by 14.44% to $1.2 billion in 2026.
• Per Business Quant, the three latest INSM Cash & Current Investments figures stand at $1.2 billion (Q1 2026), $1.4 billion (Q4 2025), and $1.7 billion (Q3 2025).